                         SEQUENCE LISTING

<110>  Louisiana State University Health Sciences Center-New 
       Orleans
 
<120>  Use of an miRNA to Reduce Proliferation of a Cancer Cell

<130>  222227-2050

<150>  US 62/026,800
<151>  2014-07-21

<160>  22    

<170>  PatentIn version 3.5

<210>  1
<211>  73
<212>  RNA
<213>  Artificial sequence

<220>
<223>  miR-3189

<400>  1
gccucaguug ccccaucugu gcccugggua ggaauauccu ggauccccuu gggucugaug       60

ggguagccga ugc                                                          73


<210>  2
<211>  21
<212>  RNA
<213>  Artificial sequence

<220>
<223>  miR-3189-3p

<400>  2
cccuuggguc ugauggggua g                                                 21


<210>  3
<211>  35
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Forward primer for ORF of p63RhoGEF

<400>  3
ggtggaattc tgcagatatg cggggggggc acaaa                                  35


<210>  4
<211>  40
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Reverse primer for ORF of p63RhoGEF

<400>  4
ccactgtgct ggatttacag ctcatcttca tccagcttgg                             40


<210>  5
<211>  35
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Forward primer for ORF of SF3B2

<400>  5
ggtggaattc tgcagatatg gcgacggagc atccc                                  35


<210>  6
<211>  47
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Reverse primer for ORF of SF3B2

<400>  6
ccactgtgct ggatctaaaa cttgaactcc ttatatttct tgctgcc                     47


<210>  7
<211>  30
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Forward primer for 3'UTR of p63RhoGEF genomic sequence

<400>  7
ccgctcgagc tggtgaaaac catgggggtg                                        30


<210>  8
<211>  41
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Reverse primer for 3'UTR of p63RhoGEF genomic sequence

<400>  8
ataagaatgc ggccgcgcag cctcggtgat ataacaaaac c                           41


<210>  9
<211>  31
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Forward primer for 3'UTR of SF3B2 genomic sequence

<400>  9
ccgctcgagt tcaagtttta ggtcccctca c                                      31


<210>  10
<211>  46
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Reverse primer for 3'UTR of SF3B2 genomic sequence

<400>  10
ataagaatgc ggccgcggag gctcaggagt gttaaatatt catctc                      46


<210>  11
<211>  38
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Forward primer for p63RhoGEF site 1 mutagenesis

<400>  11
tcagccgcct attccccttc cagcttcagg gcagtcct                               38


<210>  12
<211>  46
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Forward primer for p63RhoGEF site 2 mutagenesis

<400>  12
tggaggagaa cacctagacc cttccacttt tttctgccca aggaac                      46


<210>  13
<211>  46
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Forward primer for p63RhoGEF site 3 mutagenesis

<400>  13
cccaaggact tttttctgcc cttccaacac agtttccttc agctcc                      46


<210>  14
<211>  50
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Forward primer for SF3B2 site 1 mutagenesis

<400>  14
gaaccacctc tcccgcagtt cccttccact tgtcatttca tgttcttatt                  50


<210>  15
<211>  62
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Forward primer for SF3B2 site 2 mutagenesis

<400>  15
gacctgtttt gtaaataaag ctgtttccct tccaaagaga tgaatattta acactcctga       60

gc                                                                      62


<210>  16
<211>  23
<212>  RNA
<213>  Artificial sequence

<220>
<223>  SF3B2 Site 1 (79-86)

<400>  16
accucucccg caguucccaa gga                                               23


<210>  17
<211>  23
<212>  RNA
<213>  Artificial sequence

<220>
<223>  SF3B2 Site 2 (138-145)

<400>  17
uaaauaaagc uguuucccaa gga                                               23


<210>  18
<211>  22
<212>  RNA
<213>  Artificial sequence

<220>
<223>  p63RhoGEF Site 1 (44-51)

<400>  18
cucagccgcc uauucccaag ga                                                22


<210>  19
<211>  23
<212>  RNA
<213>  Artificial sequence

<220>
<223>  p63RhoGEF Site 2 (158-165)

<400>  19
aggagaacac cuagacccaa gga                                               23


<210>  20
<211>  23
<212>  RNA
<213>  Artificial sequence

<220>
<223>  p63RhoGEF Site 3 (176-183)

<400>  20
aaggacuuuu uucugcccaa gga                                               23


<210>  21
<211>  27
<212>  RNA
<213>  Artificial sequence

<220>
<223>  miR-3189-5p

<400>  21
guugccccau cugugcccug gguagga                                           27


<210>  22
<211>  25
<212>  RNA
<213>  Artificial sequence

<220>
<223>  anti-miR-3189-39 mirVana

<400>  22
ugccccaucu gugcccuggg uagga                                             25


